- Home
- XBIT vs III Comparison
XBIT vs III Comparison
Compare XBIT & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XBIT | III |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.2M | 251.4M |
| IPO Year | 2015 | 2007 |
Fundamental Metrics
Financial Performance| Metric | XBIT | III |
|---|---|---|
| Price | $2.48 | $5.88 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 69.8K | ★ 316.0K |
| Earning Date | 11-12-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 3.00% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $241,289,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.63 |
| P/E Ratio | ★ N/A | $31.59 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.09 | $2.95 |
| 52 Week High | $7.00 | $6.45 |
Technical Indicators
Market Signals| Indicator | XBIT | III |
|---|---|---|
| Relative Strength Index (RSI) | 50.06 | 57.00 |
| Support Level | $2.41 | $5.85 |
| Resistance Level | $2.59 | $6.08 |
| Average True Range (ATR) | 0.15 | 0.17 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 45.71 | 65.92 |
Price Performance
Historical ComparisonAbout XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About III Information Services Group Inc.
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.